In 227 of 267 patients previously refractory to other forms of therapy, sodium diphenyl hydantoinate has been found to be an effective, non-sedative and relatively non-toxic means of controlling or reducing convulsive seizures over periods varying from two months to two years. A more prolonged study on a larger series of cases is necessary to establish its place in the treatment of patients with convulsive seizures.Abstract Teaser